• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[长期抗病毒治疗后乙肝病毒所致肝硬化的可逆性]

[Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy].

作者信息

Pérez Roldán Francisco, Vives Domínguez Leopoldo, González Carro Pedro, Villafáñez García Maria Concepción, Fernández Acenero Maria Jesús, Cuesta Domínguez Rubén, Aoufi Rabih Sami, Ruíz Carrillo Francisco

机构信息

Hospital General La Mancha-Centro, Alcázar de San Juan, España.

出版信息

Gastroenterol Hepatol. 2010 Aug-Sep;33(7):498-503. doi: 10.1016/j.gastrohep.2010.04.007. Epub 2010 Jul 14.

DOI:10.1016/j.gastrohep.2010.04.007
PMID:20630622
Abstract

Reversibility of liver fibrosis or cirrhosis involves complete restoration of normal liver architecture. This phenomenon has been well documented in chronic liver diseases such as autoimmune hepatitis, biliary obstruction, hemochromatosis, nonalcoholic steatohepatitis, and viral hepatitis. There are very few reports of reversal of cirrhosis after antiviral therapy in patients with chronic hepatitis B virus (HBV) infection. We report a case of disappearance of HBV-induced liver cirrhosis after years of treatment with distinct antiviral drugs, documented by successive biopsy results. This disappearance was accompanied by normalization of platelet count, gammaglobulin titers, and radiologic findings.

摘要

肝纤维化或肝硬化的逆转涉及正常肝脏结构的完全恢复。这种现象在自身免疫性肝炎、胆管梗阻、血色素沉着症、非酒精性脂肪性肝炎和病毒性肝炎等慢性肝病中已有充分记录。关于慢性乙型肝炎病毒(HBV)感染患者抗病毒治疗后肝硬化逆转的报道非常少。我们报告一例经连续活检结果证实,在使用不同抗病毒药物治疗多年后,HBV 诱导的肝硬化消失的病例。这种消失伴随着血小板计数、γ球蛋白滴度和影像学检查结果的正常化。

相似文献

1
[Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy].[长期抗病毒治疗后乙肝病毒所致肝硬化的可逆性]
Gastroenterol Hepatol. 2010 Aug-Sep;33(7):498-503. doi: 10.1016/j.gastrohep.2010.04.007. Epub 2010 Jul 14.
2
Natural history and prognosis of hepatitis B.乙型肝炎的自然史和预后
Semin Liver Dis. 2003 Feb;23(1):47-58. doi: 10.1055/s-2003-37590.
3
Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.拉米夫定对肝移植前后乙型肝炎病毒前C区变异感染患者的疗效
Am J Gastroenterol. 1999 Mar;94(3):663-7. doi: 10.1111/j.1572-0241.1999.00933.x.
4
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.肝移植后拉米夫定单药预防乙型肝炎病毒复发中与病毒突破相关的因素。
J Med Virol. 2002 Oct;68(2):182-7. doi: 10.1002/jmv.10185.
5
Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.拉米夫定治疗后乙型肝炎所致失代偿性肝病患者的临床改善情况。
Liver Transpl. 2000 Nov;6(6):715-20. doi: 10.1053/jlts.2000.18501.
6
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.慢性丙型肝炎肝病患者中的隐匿性乙型肝炎病毒感染
N Engl J Med. 1999 Jul 1;341(1):22-6. doi: 10.1056/NEJM199907013410104.
7
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.肝移植后使用拉米夫定治疗乙型肝炎病毒感染的长期经验。
Liver Transpl. 2001 Feb;7(2):113-7. doi: 10.1053/jlts.2001.21308.
8
[Assessment and reversibility of liver fibrosis in viral hepatitis].[病毒性肝炎中肝纤维化的评估与可逆性]
Rev Prat. 2011 Jan;61(1):39-43.
9
[Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].[拉米夫定治疗慢性乙型肝炎和肝硬化患者中乙型肝炎病毒聚合酶YMDD变异的发生情况及预测因素]
Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):585-8.
10
Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.拉米夫定治疗失代偿期乙型肝炎病毒相关性肝硬化
Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):10-5.

引用本文的文献

1
Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.转化生长因子 β 中和可改善硫代乙酰胺处理大鼠的肝纤维化,减少胆管细胞癌。
PLoS One. 2013;8(1):e54499. doi: 10.1371/journal.pone.0054499. Epub 2013 Jan 17.